Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan-Reference-Cited by-同舟云学术

Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan

Published:2015-06-05 Issue:6 Volume:10 Page:e0128768
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hsin Yi-Chen,Zhuang Lai-Zhen,Yeh Kuo-Wei,Chang Cheng-Wei,Horng Jorng-Tzong,Huang Jing-Long

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden;J Askling;Arthritis Rheum,2005

2. Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy;KL Winthrop;Nat Rev Rheumatol,2013

3. Mycobacterial diseases and antitumour necrosis factor therapy in USA;KL Winthrop;Ann Rheum Dis,2013

4. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry;F Tubach;Arthritis Rheum,2009

5. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan;JL Huang;Clin Exp Rheumatol,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review;Revista Paulista de Pediatria;2024

2. Tuberculosis among children and adolescents with rheumatic diseases - case series;Pediatric Rheumatology;2023-11-10

3. Risk of tuberculosis in children with rheumatologic diseases treated with biological agents: A cross-sectional cohort study;Archives of Rheumatology;2023-02-03

4. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review;Frontiers in Pharmacology;2023-01-20

5. Spotlight on latent tuberculosis infection screening for juvenile idiopathic arthritis in two countries, comparing high and low risk patients;Advances in Rheumatology;2022-06-10